Professor Ironside told the Inquiry that there had been 178 cases of vCJD in the UK identified as definite (supported by post-mortem) or probable (no post-mortem), though the latter category was virtually certain. Read more about Professor Ironside told the Inquiry that there had been 178 cases of vCJD in the UK identified as definite (supported by post-mortem) or probable (no post-mortem), though the latter category was virtually certain.
Professor Collinge told the Inquiry about the progression of vCJD, stating that about 1 in 5,000 people will develop it during their lifetime. Read more about Professor Collinge told the Inquiry about the progression of vCJD, stating that about 1 in 5,000 people will develop it during their lifetime.
A Department of Health press release recommended the use of recombinant Factor 8 as the first choice of treatment for those with haemophilia. Read more about A Department of Health press release recommended the use of recombinant Factor 8 as the first choice of treatment for those with haemophilia.
Studies had shown that 1 in 2,000 of the population had abnormal prion protein in their appendix and may be infected with vCJD. Read more about Studies had shown that 1 in 2,000 of the population had abnormal prion protein in their appendix and may be infected with vCJD.
Sir Robert Owen was invited to be chair of the Board of Trustees of the vCJD Trust. Read more about Sir Robert Owen was invited to be chair of the Board of Trustees of the vCJD Trust.
The National CJD Research & Surveillance Unit Annual Report stated that no new case of vCJD had been identified since 2016. Read more about The National CJD Research & Surveillance Unit Annual Report stated that no new case of vCJD had been identified since 2016.
The House of Commons Science and Technology Committee advised the Government take a more precautionary approach to both vCJD risk mitigation and blood safety more generally in order to safeguard against future infections. Read more about The House of Commons Science and Technology Committee advised the Government take a more precautionary approach to both vCJD risk mitigation and blood safety more generally in order to safeguard against future infections.
In Dr Connor's written statement, she said that by 2013, 11 patients who had received transfusions from more than 80 donors and were due to undergo surgery had been identified. Read more about In Dr Connor's written statement, she said that by 2013, 11 patients who had received transfusions from more than 80 donors and were due to undergo surgery had been identified.
In Dr Connor's written statement she remarked that, by 2014, the threshold was revised so that only patients who had received transfusions donated by an aggregate total of 300 or more donors were to be considered at risk for public health purposes. Read more about In Dr Connor's written statement she remarked that, by 2014, the threshold was revised so that only patients who had received transfusions donated by an aggregate total of 300 or more donors were to be considered at risk for public health purposes.
In Sir Ian Kennedy's statement he said that lack of scientific evidence that vCJD was transmitted by blood transfusion at the time was "crucial". If such evidence became available, recipients should be identified and notified, since at that point their futures would be wholly changed, and they were entitled to know that. Read more about In Sir Ian Kennedy's statement he said that lack of scientific evidence that vCJD was transmitted by blood transfusion at the time was "crucial". If such evidence became available, recipients should be identified and notified, since at that point their futures would be wholly changed, and they were entitled to know that.